Bayer

Bayer and Puhe BioPharma enter into global license agreement for clinical phase I PRMT5 inhibitor

26 Mar 2025

New Publication Reveals the Impact of Socioeconomic Factors on Health Outcomes and Importance of Self-Care

25 Mar 2025

Articles tagged with 'forschung & innovation' | Bayer

25 Mar 2025

Bayer to present multiple new analyses of finerenone trials investigating cardiovascular outcomes and health markers

25 Mar 2025

Bayer Opens Maize Seed Facility in Zambia to Support Food Security for about 30 Million People

19 Mar 2025

Articles tagged with 'export-africa & middle east' | Bayer

19 Mar 2025

AskBio Advances Gene Therapy Clinical Trial for Limb-Girdle Muscular Dystrophy Type 2I/R9 with Dosing of First Participant in Second Cohort

07 Mar 2025

Bayer meets adjusted guidance and takes decisive action to tackle challenges

06 Mar 2025

Financial News Conference on the Full Year 2024 Results

06 Mar 2025

Bayer starts Phase II clinical study with BAY 2927088 in metastatic or unresectable HER2 mutant solid tumors

04 Mar 2025

View details about the software product Informachine News Trackers